* Treace Medical Concepts Inc TMCI.OQ reported a quarterly
adjusted loss of 12 cents per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for a loss of 12 cents per share.
* Revenue was $21.62 million; analysts expected $21.00
million.
* Treace Medical Concepts Inc's reported EPS for the quarter was
a loss of 12 cents.
* The mean earnings estimate of analysts had fallen by
about 2.1% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Treace Medical Concepts Inc shares had fallen by 9.9% this
quarter.
* The company reported a quarterly loss of $6.42 million.
* Wall Street's median 12-month price target for Treace Medical
Concepts Inc is $32.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated November 5 at 01:12 p.m.
All figures in US dollars unless otherwise stated